Immatics Management
Management criteria checks 3/4
Immatics' CEO is Harpreet Singh, appointed in Jul 2019, has a tenure of 6.67 years. total yearly compensation is €2.83M, comprised of 18.9% salary and 81.1% bonuses, including company stock and options. directly owns 1.2% of the company’s shares, worth €13.89M. The average tenure of the management team and the board of directors is 5.7 years and 4.8 years respectively.
Key information
Harpreet Singh
Chief executive officer
€2.8m
Total compensation
| CEO salary percentage | 18.86% |
| CEO tenure | 6.7yrs |
| CEO ownership | 1.2% |
| Management average tenure | 5.7yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2025 | €3m | €533k | -€196m |
| Sep 30 2025 | n/a | n/a | -€120m |
| Jun 30 2025 | n/a | n/a | -€75m |
| Mar 31 2025 | n/a | n/a | -€22m |
| Dec 31 2024 | €4m | €512k | €15m |
| Sep 30 2024 | n/a | n/a | -€49m |
| Jun 30 2024 | n/a | n/a | -€74m |
| Mar 31 2024 | n/a | n/a | -€77m |
| Dec 31 2023 | €6m | €488k | -€95m |
| Sep 30 2023 | n/a | n/a | -€84m |
| Jun 30 2023 | n/a | n/a | -€79m |
| Mar 31 2023 | n/a | n/a | -€68m |
| Dec 31 2022 | €7m | €522k | €28m |
Compensation vs Market: Harpreet's total compensation ($USD3.28M) is above average for companies of similar size in the German market ($USD1.89M).
Compensation vs Earnings: Harpreet's compensation has been consistent with company performance over the past year.
CEO
Harpreet Singh (50 yo)
Dr. Harpreet Singh, Ph D., has been Non-Executive Director of Immatics N.V. since July 1, 2021 and served as its Supervisory Director since 2021 until July 1, 2021. Dr. Singh serves as Chief Executive Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD | 6.7yrs | €2.83m | 1.2% € 13.9m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Co-Founder & Member of the Scientific Advisory Board | 26.2yrs | no data | no data | |
| Co-Founder & Chief Innovation Officer | 26.2yrs | no data | 0.30% € 3.4m | |
| Chief Operations Officer | 3yrs | no data | 0.28% € 3.3m | |
| Vice President of SEC Reporting & Accounting | 2.2yrs | no data | no data | |
| General Counsel & Secretary | 5.7yrs | no data | 0.15% € 1.7m | |
| Vice President of Marketing | 2.2yrs | no data | no data | |
| Chief Development Officer | 6.4yrs | no data | 0.41% € 4.7m | |
| Chief Business Officer & Site Head Munich | no data | no data | 0.31% € 3.6m | |
| Chief Medical Officer | 5.8yrs | no data | 0.25% € 2.9m |
Experienced Management: 4A3's management team is seasoned and experienced (5.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD | 4.7yrs | €2.83m | 1.2% € 13.9m | |
| Co-Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 4.7yrs | €309.00k | 0.065% € 750.6k | |
| Non-Executive Chairman | 4.7yrs | €329.00k | 0.30% € 3.5m | |
| Independent Vice Chair of the Board of Directors | 4.7yrs | €289.00k | 0.065% € 750.6k | |
| Member of Scientific Advisory Board | 5.8yrs | no data | no data | |
| Co-Chair of the Scientific Advisory Board | 5yrs | no data | no data | |
| Independent Non-Executive Director | 4.7yrs | €304.00k | 0.065% € 750.6k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 6.2yrs | no data | no data | |
| Co-Chair of the Scientific Advisory Board | 5.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.7yrs | no data | no data |
Experienced Board: 4A3's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/10 23:58 |
| End of Day Share Price | 2026/03/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Immatics N.V. is covered by 11 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alec Stranahan | BofA Global Research |
| Eric Schmidt | Cantor Fitzgerald & Co. |
| Yevgeniya Livshits | Chardan Capital Markets, LLC |